IC
TECX

Ikarian Capital’s Tectonic Therapeutic TECX Stock Holding History

Ikarian Capital’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.87M Buy
+157,537
New +$3.88M 0.4% 61
2025
Q3 		– Sell
-163,696
Closed -$3.25M – 200
2025
Q2 		$3.25M Sell
163,696
-105,394
-39% -$2.14M 0.62% 50
2025
Q1 		$4.77M Buy
269,090
+126,762
+89% +$4.13M 0.59% 38
2024
Q4 		$6.57M Sell
142,328
-124,817
-47% -$5.28M 0.89% 31
2024
Q3 		$8.09M Buy
267,145
+204,309
+325% +$3.73M 1.13% 24
2024
Q2 		$1.03M Sell
62,836
-2
-0% -$32 0.18% 76
2024
Q1 		$965K Buy
62,838
+2,983
+5% +$47.2K 0.11% 106
2023
Q4 		$977K Hold
59,855
– – 0.09% 101
2023
Q3 		$1.11M Buy
59,855
+48,676
+435% +$861K 0.13% 97
2023
Q2 		$127K Buy
+11,179
New +$126K 0.02% 117
2020
Q4 		– Sell
-10,417
Closed -$1.63M – 254
2020
Q3 		$1.63M Buy
+10,417
New +$2.1M 0.12% 120

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Ikarian Capital's TECX Position: Q1 2026 in Review

Ikarian Capital opened a new position in Tectonic Therapeutic (TECX) in Q1 2026: 157,537 shares worth $4.87M. The stake represents 0.4% of the portfolio and ranks #61 among its holdings. This is a return to the name: Ikarian Capital previously reported a position in TECX as recently as Q2 2025.

Ikarian Capital first reported a position in TECX in Q3 2020 and has held it in 11 quarters since. The position peaked at $8.09M in Q3 2024. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • Ikarian Capital held 157,537 shares of Tectonic Therapeutic worth $4.87M as of Q1 2026.
  • Tectonic Therapeutic was a new Ikarian Capital position in Q1 2026.
  • Tectonic Therapeutic made up 0.4% of Ikarian Capital's portfolio in Q1 2026, its #61 holding.
  • Ikarian Capital first reported a position in Tectonic Therapeutic in Q3 2020 and has held it in 11 quarters since.
  • Ikarian Capital's Tectonic Therapeutic position peaked at $8.09M in Q3 2024.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.